The severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) omicron sub-variants in Bangladesh cause mild COVID-19 and associate with similar antibody responses irrespective of natural infection or vaccination history

Objective: Genomic surveillance and seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) in Bangladesh is paramount for COVID-19 pandemic preparedness yet lagging the high-income countries due to limited resources. Methods: SARS-CoV-2 variants, COVID-19 symptoms, and serolo...

Full description

Bibliographic Details
Published in:	Heliyon
Main Authors:	Simon D. Lytton, Asish Kumar Ghosh, Rakibul Hassan Bulbul, Tasnim Nafisa, Rashid Mamunur, Christian Meier, Olfert Landt, Marco Kaiser
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Subjects:	Bangladesh COVID-19 symptoms SARS CoV-2 omicron XBB subvariant mutations anti-N-Protein IgGS-protein IgG
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024070427

Similar Items

Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
by: Asish Kumar Ghosh, et al.
Published: (2021-11-01)

Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
by: Jinghao Nicholas Ngiam, et al.
Published: (2024-12-01)

Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells
by: Revansiddha H. Katte, et al.
Published: (2024-03-01)

Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors
by: Cinzia Rizzo, et al.
Published: (2014-11-01)

Factors associated with IgG levels in adults with IgG subclass deficiency
by: James C. Barton, et al.
Published: (2021-08-01)

A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2
by: Hancong Sun, et al.
Published: (2024-12-01)

Extreme Diversity of IgGs Against Histones, DNA, and Myelin Basic Protein in the Cerebrospinal Fluid and Blood of Patients with Multiple Sclerosis
by: Irina A. Kostrikina, et al.
Published: (2020-04-01)

Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
by: Zoia R. Korobova, et al.
Published: (2022-04-01)

Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profiles
by: Selina Lehrian, et al.
Published: (2025-10-01)

Symptomatology and IgG Levels before and after SARS-CoV-2 Omicron Breakthrough Infections in Vaccinated Individuals
by: Nigella M. Paula, et al.
Published: (2024-10-01)

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023
by: Yaniv Lustig, et al.
Published: (2024-05-01)

Exploring the depths of IgG4: insights into autoimmunity and novel treatments
by: Selen Ünlü, et al.
Published: (2024-04-01)

Serial Salivary Gland Ultrasound Monitoring of Treatment Efficacy in IgG4-RD: A Case Report
by: Amy Trang, et al.
Published: (2025-07-01)

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations
by: Marjahan Akhtar, et al.
Published: (2023-12-01)

The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity
by: Sterre L. Siekman, et al.
Published: (2022-10-01)

Monitoring humoral immune response following COVID-19 immunization and booster dose: A prospective study in tunisian healthcare workers
by: Chiraz Naffouti, et al.
Published: (2025-06-01)

The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China
by: Jinjin Chu, et al.
Published: (2024-05-01)

Antibody Titer Correlates with Omicron Infection in Vaccinated Healthcare Workers
by: Maximiliano Mollura, et al.
Published: (2022-11-01)

Detection of IgA and IgG Antibodies against the Structural Proteins of SARS-CoV-2 in Breast Milk and Serum Samples Derived from Breastfeeding Mothers
by: Karen Cortés-Sarabia, et al.
Published: (2023-04-01)

Conversion Factors to Compare Serum Concentrations of Anti-HBs, Anti-SARS-CoV-2 and Anti-Tetanus Toxin IgG
by: Aurelia Knispel, et al.
Published: (2025-08-01)

Detection of Anti-Nucleocapsid Antibody in COVID-19 Patients in Bangladesh Is not Correlated with Previous Dengue Infection
by: Simon D. Lytton, et al.
Published: (2021-05-01)

Investigation of Circulating anti- Coxsackie B, anti- Polio and anti- Adeno IgG in newly diagnosed T1DM Children
by: Eman M. Saleh, et al.
Published: (2008-01-01)

Class switch toward IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccinees
by: Alex S. Siebner, et al.
Published: (2025-10-01)

A Serological Analysis of the Humoral Immune Responses of Anti-RBD IgG, Anti-S1 IgG, and Anti-S2 IgG Levels Correlated to Anti-N IgG Positivity and Negativity in Sicilian Healthcare Workers (HCWs) with Third Doses of the mRNA-Based SARS-CoV-2 Vaccine: A Retrospective Cohort Study
by: Nicola Serra, et al.
Published: (2023-06-01)

A Comparison of Natural and Therapeutic Anti-IgE Antibodies
by: Monique Vogel, et al.
Published: (2024-07-01)

Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection
by: Renata FA Pereira, et al.
Published: (2001-05-01)

MBOVPG45_0375 Encodes an IgG-Binding Protein and MBOVPG45_0376 Encodes an IgG-Cleaving Protein in Mycoplasma bovis
by: Haoran Zhao, et al.
Published: (2021-04-01)

Human T follicular helper cells and their impact on IgE and IgG4 production across allergy, malignancy, and IgG4-related disease
by: Mitsuhiro Akiyama, et al.
Published: (2025-01-01)

IgG Biomarkers in Multiple Sclerosis: Deciphering Their Puzzling Protein A Connection
by: Leonard Apeltsin, et al.
Published: (2025-03-01)

Specific IgG Antibodies (Total and Subclasses) against Saffron Pollen: A Study of Their Correlation with Specific IgE and Immediate Skin Reactions
by: Abdol-Reza Varasteh, et al.
Published: (2007-12-01)

A Kinetic Model of Antigen‐Dependent IgG Oligomerization and Complement Binding
by: Jürgen Strasser, et al.
Published: (2025-07-01)

Association between levels of IgG antibodies from vaccines and Omicron symptomatic infection among children and adolescents in China
by: Xinying Chen, et al.
Published: (2023-08-01)

IgG2 immunodeficiency: association to pediatric patients with bacterial meningoencephalitis
by: XIOMARA ESCOBAR-PÉREZ, et al.
Published: (2000-03-01)

IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease
by: Rodrigo V. Motta, et al.
Published: (2024-02-01)

Impact of estrogen on IgG glycosylation and serum protein glycosylation in a murine model of healthy postmenopause
by: Priti Gupta, et al.
Published: (2023-09-01)

Índices de falha de transferência de imunidade passiva (FTIP) em bezerros holandeses e nelores, às 24 e 48 horas de vida: valores de proteína total, de gamaglobulina, de imunoglobulina G e da atividade sérica de gamaglutamiltransferase, para o diagnóstico de FTIP Index of failure of passive transfer (FPT) in Holstein and Nelore calves at 24 and 48 hours of life: suggestion of total protein, gamma globulin, immunoglobulin G and gamma glutamyl transferase serum activity values for diagnosis of FPT
by: Francisco L. F. Feitosa, et al.
Published: (2010-08-01)

CHANGES IN THE IMMUNOLOGIC MARKERS OF ELASTIN DEGRADATION IN SUBJECTS WITH METABOLIC SYNDROME
by: Edward Mekenyan, et al.
Published: (2012-12-01)

XBB.1.16 Omicron subvariant rise to a variant of interest: Implications for global alertness and preparedness
by: Okesanya Olalekan John, B'MLS, et al.
Published: (2023-12-01)

Kinetics IgM and IgG SARS-CoV-2 in Recovery patients with Negative Evaluation RT-PCR
by: Jusup Endang, et al.
Published: (2023-11-01)

Seroprevalence of antibodies IgG/IgM anti-T. gondii in women of Coro, Venezuela
by: Saúl-García Yotsabeth, et al.
Published: (2019-06-01)